Home blood pressure (BP) measurement has been well accepted for use in the diagnosis and treatment of hypertension. However, data regarding the association between home BP levels and cardiovascular events in a general practice population aged ≥80 years are sparse.
Original article
Hypertension is both a common disease in elderly people and a leading cause of cardiovascular events. 1 The National Health and Nutrition Examination Survey (NHANES) reported that the prevalence of hypertension was 76% in adults aged 65-74 years and 82% in adults aged ≥75 years, 2 when hypertension was defined as clinic systolic blood pressure (SBP) ≥130 mm Hg and/or diastolic blood pressure (DBP) ≥80 mm Hg in keeping with a recently revised guideline (the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline). 3 The Hypertension in the Very Elderly Trial (HYVET) demonstrated that antihypertensive treatment for targeting clinic blood pressure (BP) <150/80 mm Hg reduced cardiovascular mortality compared with a placebo group among hypertensive patients aged ≥80 years. 4 The effect of lowering BP was also observed in the Systolic Blood Pressure Intervention Trial (SPRINT), the subject group of which was approximately 30% patients aged ≥75 years. In SPRINT, the strict clinic SBP control group (<120 mm Hg) showed a reduced incidence of cardiovascular events and increased adverse events compared with the standard SBP control group (<140 mm Hg). 5 Thus, in elderly hypertensive patients, clinic BP control has been shown to achieve a reduction in cardiovascular events.
The use of home BP measurement has been well accepted as a tool contributing to the diagnosis and treatment of hypertension, based on accumulated findings that home BP measurement provides reproducibility of BP measurement comparable with that by clinic BP and may even exceed clinic BP in its association with organ damage and cardiovascular outcomes. 3, 6, 7 However, data are lacking regarding the association between home BP levels and cardiovascular events in very elderly populations. In a population aged ≥80 years from the International Database on Home Blood Pressure in Relation to Cardiovascular Outcome (IDHOCO), a J-or U-curve association between home BP levels and cardiovascular events was observed, especially in the population with antihypertensive treatment. 8 Accordingly, that study raised concerns about the benefit of lowering the home BP level in very elderly individuals. However, that study had important limitations that evoke several questions.
First, Asian populations have provided more evidence regarding the contribution of BP to cardiovascular outcomes Morning Home Blood Pressure and Cardiovascular Events in a Japanese General Practice Population Over 80 Years Old: The J-HOP Study compared with western populations. 9 Because the IDHOCO study analyzed a heterogeneous population from Asian and western countries, it is possible that home BP is linearly associated with cardiovascular outcomes in selected Asian populations. Second, several studies have demonstrated that BP measured in the morning provided more prognostic power than that measured in the evening. [10] [11] [12] This observation may also be found in patient populations aged >80 years, but to the best of our knowledge, this has never been investigated by a stratified analysis according to morning and evening home BP levels. Third, the IDHOCO study was communitybased and not a clinical practice setting.
To address this gap in knowledge, we examined the association between home BP levels and cardiovascular outcomes in a Japanese general practice population aged ≥80 years from the Japan Morning Surge-Home Blood Pressure (J-HOP) study.
METHODS

Study design
This study was a post-hoc analysis of the J-HOP study, which is a prospective observational study (University Hospital Medical Information Network Clinical Trials Registry, UMIN000000894) of 4,310 patients with a history of and/or risk factors for cardiovascular disease who were recruited between 2005 and 2012 and followed-up through March 2015 from primary clinical practices and university hospitals. 11 The details of the J-HOP study design and methods are described in the Supplementary Data. The present study included 349 patients ≥80 years old from the J-HOP study. All participants provided written informed consent, and the Institutional Review Board of Jichi Medical School approved the study.
BP and other measurements
Further details of the present study's methods are described in the Supplementary Data. Briefly, 3 clinic BP readings were taken at 15-second intervals on 2 different occasions, and their mean (6 readings) was used as the clinic BP. Self-measured home BP values were obtained according to the Japanese Society of Hypertension guidelines for self-monitoring of BP at home. 13 Three home BP readings were taken at 15-second intervals with the subject in a seated position in both the morning (within 1 hour of waking and before taking antihypertensive medication) and the evening (before going to bed). All participants were instructed to measure home BP for 14 consecutive days. After the first day's home BP measurements were excluded, the final averages of the remaining measurements in this study were 10.9 ± 3.0 days and 10.7 ± 3.1 days in morning and evening home BP, respectively.
Clinic and home BP values were measured using the same validated, automatic, and oscillometric device (HEM-5001; Omron Healthcare, Kyoto, Japan). 14 In addition, to avoid reporting bias, BP data were automatically stored in the memory of the BP device and were downloaded to a computer by a physician or nurse during a participant's clinic visits. In this analysis, we evaluated the morning, evening, and average of morning and evening home BP values separately. Laboratory methods are presented in the Supplementary Data. Each participant's history of cardiovascular disease, including angina pectoris, myocardial infarction, and stroke, was ascertained at baseline.
Ascertainment of outcomes
Each participant's vital status was ascertained through March 2015. As the composite cardiovascular outcome, we assessed the incident composite cardiovascular outcomes during follow-up, including fatal and nonfatal coronary artery disease and sudden death within 24 hours of the abrupt onset of symptoms, stroke (fatal and nonfatal) events, heart failure (fatal and hospitalized), and aortic dissection. In the J-HOP study, we observed that higher home BP was associated with an increased risk for stroke but not for coronary artery disease. 11 We therefore evaluated stroke and nonstroke events separately. Additional details are given in the Supplementary Data.
Statistical analyses
Descriptive statistics are presented as the mean ± SD and/or proportions. We separately analyzed the association between home BP and the composite cardiovascular outcome and the association of stroke and nonstroke incidence. We performed using the Fine and Gray model to take into account the competing risk from death 15 because a very elderly population is at high risk for fatal events besides cardiovascular complications. Using Cox proportional hazards models, we calculated the hazard ratios (HRs) and 95% confidence intervals (CIs) of composite cardiovascular events, stroke, and nonstroke events associated with the tertiles of BP category and BP levels as a continuous variable. When we analyzed the association between the tertiles of BP category and cardiovascular outcomes, we defined the reference as the lowest number of events per 1,000 person-years. The proportionality assumption for the Cox analyses was confirmed graphically and via the inclusion of a time-by-BP interaction.
To analyze the association between BP levels as a continuous variable and cardiovascular outcomes, we calculated the HRs in an unadjusted model (Model 1) and after adjusting for a composite risk score (Model 2) and clinic SBP or DBP (Model 3). Composite risk scores are a useful approach to controlling for confounders when there are a limited number of outcomes. 16 A composite risk score was created in the overall J-HOP population in the current study by determining the 4-year predicted probabilities for cardiovascular outcomes using Cox regression models including the covariates demographic variables (age and sex) and clinical and behavioral characteristics at baseline (body mass index; smoking status; prevalent diabetes; prevalent angina pectoris, myocardial infarction, or stroke; total cholesterol; high-density lipoprotein cholesterol; and statin or antihypertensive medication use). These covariates were selected a priori because they have been reported to show correlations with both BP 17 and cardiovascular risk 18 and could potentially confound the association between BP and cardiovascular risk.
All statistical analyses were performed with R software, ver. 3.3.1 (The R Foundation for Statistical Computing, Vienna, Austria), Stata ver. 15 software (Stata Corp, College Station, TX), and SAS system, ver. 9.4 (SAS Institute, Cary, NC). Two-sided P values <0.05 were defined as significant. Table 1 provides the baseline characteristics of the 349 patients aged >80 years. The average age was 82.8 ± 2.8 (range 80-96 years) years old. Of the 349 patients, 90% were being treated with antihypertensive drugs and 17% had had pre-existing cardiovascular disease, such as angina pectoris, myocardial infarction, or stroke. The mean clinic BP (SBP/DBP) was 145.6 ± 19.2/74.4 ± 10.6 mm Hg; the mean morning home BP and evening home BP were 146.3 ± 18.7/73.5 ± 10 mm Hg and 133.4 ± 17.4/67.8 ± 9.8 mm Hg, respectively.
RESULTS
During a median follow-up of 3.0 years (5th to 95th percentile interval, 1.0-6.9 years), 13 strokes and 19 nonstroke events occurred: sudden death, n = 2; angina pectoris, n = 4; myocardial infarction, n = 3; heart failure, n = 10, and 18 noncardiovascular deaths occurred. Table 2 shows the HRs and 95% CIs for the incident composite cardiovascular events according to the tertiles of morning, evening, and clinic SBP using an unadjusted Cox hazard model. Supplementary Table S1 shows the prevalence of stroke or nonstroke events and SBP indexes. There were no findings indicating a J-or U-shaped association between all the SBP indexes and incident composite cardiovascular events, stroke, and nonstroke events.
In the unadjusted model, higher morning SBP was a significant risk of composite cardiovascular and stroke events (Model 1 in Table 3 ). This association largely remained after adjustment by the 4-year cardiovascular risk scores (Model 2 in Table 3 ) and after adjustment by the 4-year cardiovascular risk scores and clinic SBP (Model 3 in Table 3 ).
Concerning the association between the tertiles of morning, evening, and clinic DBP and outcome, there were findings indicating a J-or U-shaped association between evening DBP and incident composite cardiovascular or nonstroke events (Supplementary Tables S2 and S3 ).
Higher morning DBP as continuous variable tended to be associated with a significant risk of stroke events in the unadjusted model (Supplementary Table S4 ). This association remained after adjustment by the 4-year cardiovascular risk scores and after adjustment by the 4-year cardiovascular risk scores and clinic DBP (Supplementary Table S4 ).
Placement in the top tertile of average home SBP and DBP tended to confer a risk of composite cardiovascular events (Supplementary Table S5 ). There was no difference in the prevalence of stroke and nonstroke events among the tertiles of average home SBP and DBP (Supplementary Table S6 ). Higher average home SBP as continuous variable tended to be associated with composite cardiovascular events in unadjusted model (Supplementary Table S7 ). Concerning stroke events, higher average home SBP was a significant risk even after adjustment by the 4-year cardiovascular risk scores and clinic SBP, whereas this association in average home DBP was marginal (Supplementary Table S7 ).
DISCUSSION
In the J-HOP study, a nationwide practice-based study of 4,310 Japanese with a prior history of and/or risk factors for cardiovascular disease, 8.1% of the participants were ≥80 years of age and underwent a median follow-up of 3.0 years. Our present findings showed that in a Japanese general practice population aged ≥80 years, an increased morning home SBP level was independently associated with composite cardiovascular events and stroke events, and morning home DBP was also associated with stroke events. Average home DBP 70.5 ± 9.4
Average home PR 69.1 ± 15.0
Data are the means ± SD or percentages. Average home SBP, DBP, and PR are the average of morning and evening SBP, DBP, and PR, respectively. Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; PR, pulse rate; SBP, systolic blood pressure.
These associations were not found in evening home BP. Clinic BP measured by a similar validated device for home BP was also not associated with cardiovascular events.
There are 2 previous studies of the association between home BP levels and cardiovascular outcomes in a population aged ≥80 years. The Predictive Values of Blood Pressure and Arterial Stiffness in an Institutionalized Very Aged Population (PARTAGE) enrolled 1,126 subjects ≥80 years old, and the studys' authors found that self-measured BP at baseline was not associated with total mortality or cardiovascular events during the 2-year follow-up; however, the subjects of that study were residents of nursing homes. 19 Aparicio et al. 8 selected a population older than 80 years of age from the IDHOCO study and combined the dataset of a prospective study regarding home Clinic SBP n/a n/a n/a n/a n/a n/a Adjusted HRs (95% CIs) for the risk of composite cardiovascular events, stroke events, and nonstroke events with a 10 mm Hg higher morning, evening, and clinic SBP are shown. Adjusted factors for Model 2 included the 4-year cardiovascular risk scores comprising demographic variables (age and sex) and clinical and behavioral characteristics (body mass index; smoking status; prevalence of diabetes; pre-existing angina pectoris, myocardial infarction, or stroke; total cholesterol; high-density lipoprotein cholesterol; and statin or antihypertensive medication use). Adjustment factors for Model 3 included the 4-year cardiovascular risk scores comprising demographic variables, clinical and behavioral characteristics, and clinic SBP. Abbreviations: BP, blood pressure; CI, confidence interval; HR, hazard ratio; SBP, systolic blood pressure.
BP measurements from several countries; the results revealed that home BP was linearly associated with cardiovascular outcomes in the 202 untreated patients, and a J-or U-curve association between home BP and outcomes existed in the 173 treated hypertensive patients. However, the subjects of that study were enrolled from a general population. To the best of our knowledge, the present study is the first to investigate the association between home BP levels and cardiovascular outcomes in a population aged ≥80 years in a clinical setting.
The results of our present analyses demonstrated a positive linear relationship between morning home BP and cardiovascular events (especially stroke events) in individuals aged ≥80 years. The majority of the participants in our present series were being treated for hypertension (90%). Although the IDHOCO study demonstrated, in a treated hypertensive population, that the association between home SBP and cardiovascular outcome shows a J-or U-curve relationship, 8 the differing characteristics of the populations under study might explain this diversity. The population of the IDHOCO study was drawn from several countries, including Japan, Greece, and Argentina. The prevalence of cardiovascular risk and events has been reported to differ depending on countries or races. In Japanese individuals in particular, stroke events are more common than coronary events. 20 In addition, a difference has been observed in the contribution of cardiovascular risk to cardiovascular events. Perkovic et al. 9 reported that the contribution of BP to cardiovascular events in an Asian population was steeper than that in a western population regardless of age. Therefore, the possibility that the variation in results among studies might have depended on different racial characteristics and contributions of cardiovascular risk should be carefully considered. A previous study also supports our findings. The morning BP surge evaluated by ambulatory BP monitoring has been reported to be an independent cardiovascular disease risk factor, [21] [22] [23] and its incidence increased with aging. 24 In the present study, morning home BP was clearly associated with cardiovascular outcomes, whereas clinic BP was not. Two previous studies, the PARTAGE and IDHOCO investigations, did not explore the prognostic difference between clinic BP and home BP. 8, 19 The present study is the first to explore the impact on cardiovascular outcomes between office and home BP in a clinical population aged >80 years. Although out-of-clinic BP measurements are recommended in international guidelines, 3, 6, 7 clinic BP measurement has still been the golden standard method for the management of hypertension. Our present findings suggest that home BP measurement might be beneficial compared with clinic BP measurement in very elderly individuals.
The data indicating no association between evening home BP and cardiovascular outcomes in this study were consistent with previous results. In the entire population of the J-HOP study, evening BP was not linearly associated with stroke or coronary events. 11 Although the PARTAGE and IDHOCO studies performed measurement of not only morning but also evening home BP, the studies' authors did not present the results stratified by morning and evening home BP. 8, 19 Home BP measurement has shown superior reproducibility and reliability compared with office BP measurement. However, we observed that evening home BP had inferior reliability compared with morning home BP during the day. 25 Although international guidelines recommend both morning and evening home BP measurement, 3, 6, 7 the morning home BP measurement might be more important. Actually, in the present study, the average of morning and evening home SBP values diluted the prognostic impact for composite cardiovascular outcomes compared with morning home SBP alone.
Although there are several findings indicating a J-or U-shaped association between clinic DBP levels and cardiovascular risks, 26, 27 the association of home DBP is limited. To the best of our knowledge, only 1 report showed that lower home DBP tended to show an increased risk of stroke; this tendency was not significant. 28 The results of the present study showed that the lowest tertile of evening home DBP presented a risk of composite cardiovascular and nonstroke events. Further studies will be needed to investigate the association between home DBP measurement and the risk of each phenotype of cardiovascular outcome in very old individuals in a clinical setting.
There are several limitations in this study. First, the follow-up period was relatively short compared with previous studies, but for investigations of the prognostic power of BP for cardiovascular outcomes in very elderly populations, a short-term follow-up might be superior to a long-term follow-up. A recent study showed that the mean office BP decreased for more than a decade before death in patients aged ≥60 years, independently of hypertension treatment. 29 Therefore, a long-term follow-up of very elderly individuals might underestimate the real contribution of BP to cardiovascular outcomes. Second, the sample size was small because it was difficult to recruit very elderly individuals from clinical settings who were able to perform self-measured home BP (the ≥80-year-old patients were 8.1% of the entire J-HOP population). This tendency was consistent with other general population studies (Ohasama study, 5.2%; Didima study, 5.4%). 8 Third, especially for the elderly, a differential association between BP and cardiovascular events has been observed when stratified according to physical inactivity, 30 but information on physical inactivity was not available in this analysis. Fourth, given the small number of events, our results are not sufficient to make any definitive statements. Finally, whether our findings can be generalized to other populations or races remains to be determined.
In conclusion, we showed the association between home BP and cardiovascular events in a very elderly Japanese population drawn from clinical settings. Morning home BP showed a positive linear association with cardiovascular events, especially stroke incidence, whereas this association was not found in clinic BP or evening home BP. Based on these results, in very elderly Asian individuals, measuring morning home BP might be important in clinical settings regardless of the individuals' clinic BP levels. Further study is needed to determine whether hypertensive treatment titrated by morning home BP reduces the risk of cardiovascular outcomes, taking adverse events into consideration for very elderly people.
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